Newsletters - May 2003

Newsletters - May 2003

Sami Labs, India, an associate group of Sabinsa Corporation, has completed the recruitment of volunteers for a 48 subject Clinical Study. The first round of volunteers have gone through Phase-I trials as well . ClinWorld Inc., subsidiary of the US based company, is organizing the study under ICH Guidelines. The final data will be available in the middle of summer 2003. Sami Labs is the producer of Coleus forskohlii extracts for Sabinsa Corporation.

REGULATORY DOSSIERS AVAILABLE
Sabinsa has Type II Drug Master File (DMF) available for the following products: Glucosamine sulfate potassium salt, Capsaicin USP and Gugulipid®. A facilities list file, type II for DigeZyme® is also available.

LOOK FOR US AT THE SCC SHOW
Sabinsa Corporation will participate in the Supplier's Day event on Tuesday, May 13 & Wednesday, May 14, 2003 (9:00 am to 4:00 pm) at the Meadowlands Convention Center, Secaucus, NJ. This annual event hosted by the New York Chapter of the Society of Cosmetic Chemists, is one of the largest shows of its kind anywhere in the world. Exhibits include a wide range of products and services related to the cosmetics industry, offering a comprehensive insight to professionals in the field.

Visit the Sabinsa booth to learn about our expanding range of natural extracts, fine chemicals and specialty chemicals and their versatile applications.

Shaheen Majeed (Executive Assistant to the CEO) and Kavita Subramanian (Manager, New Business Deve lopment) would be happy to share product information and application guidelines with you.

Clinical study validates efficacy of Nutritional bar

A snack bar formulation developed by Sabinsa Corporation was tested for clinical efficacy in supporting healthy blood sugar levels in sixteen type 2 diabetes patients (8 men and 8 women), 34 to 67 years of age.
The results of the open field, physician controlled study indicate that regular consumption of three bars per day for eight weeks, effects a gradual significant decline in blood fasting glucose levels and levels of glycosylated hemoglobin.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US